217
Views
11
CrossRef citations to date
0
Altmetric
Original Article

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial

, &
Pages 1279-1284 | Accepted 15 Jan 2008, Published online: 20 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pieter-Jan Cortoos, Christa Gilissen, Gert Laekeman, Willy E. Peetermans, Hilde Leenaers, Luc Vandorpe & Steven Simoens. (2013) Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia. Scandinavian Journal of Infectious Diseases 45:3, pages 219-226.
Read now

Articles from other publishers (10)

Mingye Zhao, Zhuoyuan Chi, Xingming Pan, Yue Yin & Wenxi Tang. (2022) Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis. International Journal of Environmental Research and Public Health 19:8, pages 4816.
Crossref
Xiwen Du, Yi Han, Yifei Jian, Liping Chen & Jianwei Xuan. (2021) Clinical Benefits and Cost-Effectiveness of Moxifloxacin as Initial Treatment for Community-Acquired Pneumonia: A Meta-Analysis and Economic Evaluation. Clinical Therapeutics 43:11, pages 1894-1909.e1.
Crossref
Cássia F.B. Caurio, Odelta S. Allende, Roger Kist, Izadora C.S. Vasconcellos, Francieli P. Rozales, Maikel Reck-Kortmann, Daiane F. Dalla Lana, Ana Paula Alegretti, Giácomo B. Neto & Alessandro C. Pasqualotto. (2020) Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system. The Brazilian Journal of Infectious Diseases 24:3, pages 191-200.
Crossref
Marufa Sultana, Abdur Razzaque Sarker, Nausad Ali, Raisul Akram & Lisa Gold. (2019) Economic evaluation of community acquired pneumonia management strategies: A systematic review of literature. PLOS ONE 14:10, pages e0224170.
Crossref
Falk Schwendicke, Michael Stolpe & Frauke Müller. (2017) Professional oral health care for preventing nursing home-acquired pneumonia: A cost-effectiveness and value of information analysis. Journal of Clinical Periodontology 44:12, pages 1236-1244.
Crossref
Simone Gattarello. (2015) What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy. Current Infectious Disease Reports 17:10.
Crossref
Timothy E. Albertson, Brian M. Morrissey & Andrew L. Chan. (2012) Are Fluoroquinolones Superior Antibiotics for the Treatment of Community-Acquired Pneumonia?. Current Infectious Disease Reports 14:3, pages 317-329.
Crossref
Dheeraj Gupta, Ritesh Agarwal, AshutoshNath Aggarwal, Navneet Singh, Narayan Mishra, GC Khilnani, JK Samaria, SN Gaur & SK Jindal. (2012) Guidelines for diagnosis and management of community-and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India 29:6, pages 27.
Crossref
K.B. Bamford, M. Desai, M.J. Aruede, W. Lawson, A. Jacklin & B. Dean Franklin. (2011) Patients' views and experience of intravenous and oral antimicrobial therapy: room for change. Injury 42, pages S24-S27.
Crossref
Sergio Carbonara, Laura Monno, Benedetta Longo & Gioacchino Angarano. (2009) Community-acquired pneumonia. Current Opinion in Pulmonary Medicine 15:3, pages 261-273.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.